These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 31840206)
1. Effects of rivaroxaban on activated clotting time in catheter ablation for atrial fibrillation in Chinese patients. Songqun H; Chunling W; Zhifu G; Xinmiao H; Jiang C J Interv Card Electrophysiol; 2020 Dec; 59(3):509-516. PubMed ID: 31840206 [TBL] [Abstract][Full Text] [Related]
2. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation]. Yang L; Gao LJ; Yin XM; Guo BL Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):602-607. PubMed ID: 31434430 [No Abstract] [Full Text] [Related]
3. Determinants of Heparin Dosing and Complications in Patients Undergoing Left Atrial Ablation on Uninterrupted Rivaroxaban. Enriquez AD; Churchill T; Gautam S; Chinitz JS; Barbhaiya CR; Kumar S; John RM; Tedrow UB; Koplan BA; Stevenson WG; Michaud GF Pacing Clin Electrophysiol; 2017 Feb; 40(2):183-190. PubMed ID: 28054374 [TBL] [Abstract][Full Text] [Related]
4. Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Komtasubara I; Kusachi S Clin Drug Investig; 2016 Oct; 36(10):837-48. PubMed ID: 27389243 [TBL] [Abstract][Full Text] [Related]
5. Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation. Hamam I; Daoud EG; Zhang J; Kalbfleisch SJ; Augostini R; Winner M; Tsai S; Rhodes TE; Houmsse M; Liu Z; Love CJ; Tyler J; Sachdev M; Weiss R; Hummel JD Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):491-6. PubMed ID: 23685538 [TBL] [Abstract][Full Text] [Related]
6. Effect of uninterrupted dabigatran or rivaroxaban on achieving ideal activated clotting time to heparin response during catheter ablation in patients with atrial fibrillation. Xin Q; Zhang C; Wang YJ; Li J; Chen T; Li SX; Wang W; Yang Y; Song WJ; Zhou J; Shi XM J Geriatr Cardiol; 2022 Aug; 19(8):565-574. PubMed ID: 36339467 [TBL] [Abstract][Full Text] [Related]
7. Safety of a single bolus administration of heparin without the measurement of activated clotting time during cryoballoon ablation: a prospective randomized controlled trial. Shin DG; Lee M; Ahn J; Han SJ; Lim HE J Interv Card Electrophysiol; 2023 Mar; 66(2):463-470. PubMed ID: 36044101 [TBL] [Abstract][Full Text] [Related]
8. Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation. Payne JE; Koerber SM; Bickel T; Ghadban R; Flaker G; Gautam S J Interv Card Electrophysiol; 2020 Aug; 58(2):185-191. PubMed ID: 31230179 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of uninterrupted rivaroxaban taken preoperatively for radiofrequency catheter ablation of atrial fibrillation compared to uninterrupted warfarin. Tao S; Otomo K; Ono Y; Osaka Y; Hirao T; Koura K; Manno T; Ueshima D; Shimizu S; Isobe M; Hirao K J Interv Card Electrophysiol; 2017 Mar; 48(2):167-175. PubMed ID: 27943112 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of Rivaroxaban anticoagulant therapy in the treatment of atrial fibrillation cryoablation]. Di CY; Wan Z; Lin WH Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(33):2591-2594. PubMed ID: 28881533 [No Abstract] [Full Text] [Related]
12. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation. Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495 [TBL] [Abstract][Full Text] [Related]
13. Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs. Sairaku A; Morishima N; Matsumura H; Amioka M; Maeda J; Watanabe Y; Nakano Y J Interv Card Electrophysiol; 2021 Sep; 61(3):551-557. PubMed ID: 32808083 [TBL] [Abstract][Full Text] [Related]
14. Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin. Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S J Cardiovasc Electrophysiol; 2018 Jun; 29(6):835-843. PubMed ID: 29533476 [TBL] [Abstract][Full Text] [Related]
15. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation. Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868 [TBL] [Abstract][Full Text] [Related]
16. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study. Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959 [TBL] [Abstract][Full Text] [Related]
17. The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban. Brendel LC; Dobler F; Hessling G; Michel J; Braun SL; Steinsiek AL; Groha P; Eckl R; Deisenhofer I; Hyseni A; Roest M; Ott I; Steppich B J Interv Card Electrophysiol; 2017 Sep; 49(3):237-244. PubMed ID: 28735423 [TBL] [Abstract][Full Text] [Related]
18. Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures. Benali K; Verain J; Hammache N; Guenancia C; Hooks D; Magnin-Poull I; Toussaint-Hacquard M; de Chillou C; Sellal JM J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575348 [TBL] [Abstract][Full Text] [Related]
19. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin. Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285 [TBL] [Abstract][Full Text] [Related]
20. Use of a New Standardized Unfractionated Heparin Protocol for Left-Sided Ablation Procedures Improves Time in the Therapeutic ACT Range. Ural KG; Moridzadeh SS; Busch EH; Masri OE; Burton JH; Morin DP J Cardiothorac Vasc Anesth; 2024 Jan; 38(1):67-72. PubMed ID: 38030427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]